$8.19
0.638.33%
最終更新: Oct 9, 4:00 PM
Benzinga
Benzinga
Benzinga
土曜日, 10 10
Benzinga
© 2026 Benzinga | All Rights Reserved
Immunic (IMUX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.18 | $-0.91 | $-1.10 | $-1.80 |
| Actual | $-0.80 | $-1.08 | $-0.70 | $-1.30 |
| Surprise | +32.2% | -18.7% | +36.4% | +27.8% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.93 | $-0.81 | $-0.60 | $-0.62 |
| Revenue | ||||
| Consensus | — | — | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.80 | $-1.18 | 32.2 % |
| Q1 | May 13, 2026 | $-1.08 | $-0.91 | -18.7 % |
| Q4 | Feb 26, 2026 | $-0.70 | $-1.10 | 36.4 % |
| Q3 | Nov 13, 2025 | $-1.30 | $-1.80 | 27.8 % |